Human neutrophils express the interleukin-15 receptor α chain (IL- 15Rα) but not the IL-9Rα component

Clinical Immunology and Immunopathology

Volumn 88, Issue 3, 1998, Pages 232-240

  Girard, Denis ^a   Boiani, Norman ^b   Beaulieu, André D ^c  

^a INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE   (Canada)

^b AMGEN INC   (United States)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

Interleukin 15; Interleukin 9; Neutrophils; Receptors

Indexed keywords

INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 9; INTERLEUKIN 9 RECEPTOR; MONOCLONAL ANTIBODY; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 15; RECOMBINANT INTERLEUKIN 2; RECOMBINANT INTERLEUKIN 4; RECOMBINANT INTERLEUKIN 7; RECOMBINANT INTERLEUKIN 9; SUPEROXIDE;

APOPTOSIS; ARTICLE; CELL SHAPE; CELL SPREADING; CYTOKINE RELEASE; CYTOLOGY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NEUTROPHIL; NORMAL HUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RECEPTOR UPREGULATION; RNA SYNTHESIS; SHEEP ERYTHROCYTE;

EID: 0032168074     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1998.4576     Document Type: Article

References (35)

1. Liu J. H., Wei S., DeWayne U., Epling-Burnette P. K., Leonard W. J., Djeu J. Y. Expression of the interleukin-2 receptor γ chain on human neutrophils. Blood. 84:1994;3870-3875.
2. Nakarai T., Roberston M. J., Streuli M., Wu Z., Ciardelli T. L., Smith K. A., Ritz J. Interleukin 2 receptor γ chain expression on resting and activated lymphoid cells. J. Exp. Med. 180:1994;241-251.
3. Girard D., Gosselin J., Heitz D., Paquin R., Beaulieu A. D. Effects of interleukin-2 on gene expression in human neutrophils. Blood. 86:1995;1170-1176.
4. c. Immunol. Rev. 138:1994;61-86.
5. Leonard W. J. Dysfunctional cytokine receptor signaling in severe combined immunodeficiency. J. Invest. Med. 44:1996;304-311.
6. Sugamura K., Asao H., Kondo M., Tanaka N., Ishii N., Ohbo K., Nakamura M., Takeshita T. The interleukin-2 receptor γ chain: Its role in the multiple cytokine receptor complexes and T cell development in XSCID. Annu. Rev. Immunol. 14:1996;179-205.
7. Kondo M., Takeshita T., Ishii N., Nakamura M., Watanabe S., Arai K. I., Sugamura K. Sharing of the interleukin-2 (IL-2) receptor γ chain between receptor for IL-2 and IL-4. Science. 262:1993;1874-1877.
8. Giri J. G., Anderson D. M., Kumaki S., Park L. S., Grabstein K. H., Cosman D. IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2. J. Leukocyte Biol. 57:1995;763-766.
9. Giri J. G., Kumaki S., Ahdieh M., Friend D. J., Loomis A., Shanebeck K., Dubose R., Cosman D., Park L. S., Anderson D. M. Identification and cloning of a novel IL-15 binding protein that is structurally related to the α chain of the IL-2 receptor. EMBO J. 14:1995;3654-3663.
10. Girard D., Paquin R., Beaulieu A. D. Responsiveness of human neutrophils to interleukin-4: Induction of cytoskeletal rearrangements,de novo. Biochem. J. 325:1997;147-153.
11. c. Clin. Immunol. Immunopathol. 83:1997;264-271.
12. Djeu J. Y., Liu J. H., Wei S., Rui H., Pearson C. A., Leonard W. J., Blanchard D. K. Function associated with IL-2 receptor-β on human neutrophils. Mechanism of activation of antifungal activity againstCandida albican. J. Immunol. 150:1993;960-970.
13. Girard D., Paquet M. E., Paquin R., Beaulieu A. D. Differential effects of IL-15 and IL-2 on neutrophils: Induction of cytoskeletal rearrangement and increased ability to prevent apoptosis by IL-15. Blood. 88:1996;3176-3184.
14. Girard D., Paquin R., Naccache P. H., Beaulieu A. D. Effects of interleukin-13 on human neutrophil functions. J. Leukocyte Biol. 59:1996;412-419.
15. Gosselin J., Paquin R., Beaulieu A. D. Epstein-Barr virus modulatesde novo. Blood. 86:1995;2789-2798.
16. Demoulin J. B., Uyttenhove C., Van Roost E., de Lestre B., Donckers D., Van Snick J., Renauld J. C. A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9. Mol. Cell. Biol. 16:1996;4710-4716.
17. Ishii N., Takeshita T., Kimura Y., Tada K., Kondo M., Nakamura M., Sugamura K. Expression of the IL-2R gamma chain on various populations in human peripheral blood. Int. Immunol. 6:1994;1273-1277.
18. Naccache P. H., Therrien S., Caon A. C., Liao N., Gilbert C., McColl S. R. Chemoattractant-induced cytoplasmic pH changes and cytoskeletal reorganization in human neutrophils. J. Immunol. 142:1989;2438-2444.
19. Lee A., Whyte M. K. B., Haslett C. Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J. Leukocyte Biol. 54:1993;283-288.
20. Whyte M. K. B., Meagher L. C., MacDermot J., Haslett C. Impairment of function in aging neutrophils is associated with apoptosis. J. Immunol. 150:1993;5124-5134.
21. Boey H., Rosenbaum R., Castracane J., Borish L. Interleukin-4 is a neutrophil activator. J. Allergy Clin. Immunol. 83:1989;978-984.
22. Darzynkiewicz Z., Bruno S., Delbino G., Gorczyca W., Hotz M. A., Lassota P., Traganos F. Features of apoptotic cells measured by flow cytometry. Cytometry. 13:1992;795-808.
23. Jablons D., Bolton E., Mertins S., Rubin M., Pizzo P., Rosenberg S. A., Lotze M. T. IL-2-based immunotherapy alters circulating neutrophil Fc receptor expression and chemotaxis. J. Immunol. 144:1990;3630-3636.
24. Chang M. S., Engel G., Benedict C., Basu R., McNinch J. Isolation and characterization of the human interleukin-9 receptor gene. Blood. 83:1994;3199-3205.
25. Schumann R. R., Nakarai T., Gruss H. J., Brach M. A., von Arnim U., Kirschning C., KarawaJew L., Ludwig W. D., Renauld J. C., Ritz J., Herrmann F. Transcript synthesis and surface expression of the interleukin-2 receptor (alpha-, beta-, and gamma-chain) by normal and malignant myeloid cells. Blood. 87:1996;2419-2427.
26. Pericle F., Liu J. H., Diaz J. I., Blanchard D. K., Wei S., Forni G., Djeu J. Y. Interleukin-2 prevention of apoptosis in human neutrophils. Eur. J. Immunol. 24:1994;440-444.
27. Wei S., Blanchard D. K., Liu J. H., Leonard W. J., Djeu J. Y. Activation of tumor necrosis factor-α production from human neutrophils via IL-2Rβ J. Immunol. 150:1993;1979-1987.
28. Wei S., Liu J. H., Blanchard D. K., Djeu J. Y. Induction of IL-8 gene expression in human polymorphonuclear neutrophils by recombinant IL-2. J. Immunol. 152:1994;3630-3636.
29. Carson W. E., Giri J. G., Lindemann M. J., Linett M. L., Ahdieh M., Paxton R., Anderson D., Eisenmann J., Grabstein K., Caligiuri M. A. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 180:1994;1395-1403.
30. Armitage R. J., Macduff B. M., Eisenman J., Paxton R., Grabstein K. H. IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J. Immunol. 154:1995;483-490.
31. McInnes I. B., al-Mughales J., Field M., Leung B. P., Huang F. P., Dixon R., Sturrock R. D., Wilkinson P. C., Liew F. Y. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat. Med. 2:1996;175-182.
32. Isomaki P., Luukkainen R., Toivanen P., Punnonen J. The presence of interleukin-13 in rheumatoid synovium and its antiinflammatory effects on synovial fluid macrophage from patients with rheumatoid arthritis. Arthritis Rheum. 39:1996;1693-1702.
33. Isomaki P., Luukkainen R., Toivanen P., Punnonen J. The presence of interleukin-13 in rheumatoid synovium and its antiinflammatory effects on synovial fluid macrophage from patients with rheumatoid arthritis. Arthritis Rheum. 39:1996;1693-1702.
34. Collotta F., Re F., Muzio M., Bertini R., Polentarutti N., Sironi M., Giri J. G., Dower S. K., Sims J. E., Mantovani A. Interleukin-1 type II receptor: A decoy target for IL-1 that is regulated by IL-4. Science. 261:1993;472-477.
35. Rosen G. M., Pou S., Ramos C. L., Cohen M. S., Britigan B. E. Free radicals and phagocytic cells. FASEB J. 9:1995;200-209.